Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023
PLOS One · 30.07.2026 · 21 (7) · e0354799
DOI: 10.1371/journal.pone.0354799 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.07.2026. Verfasst von Chizu Nishi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Mimihara General Hospital, Sakai, Osaka, Japan. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Streptococcal Infections, Pregnancy Complications, Infectious. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Group B Streptococcus (GBS) colonization in pregnant women is a major risk factor for neonatal diseases; however, molecular epidemiological studies on GBS in Japan remain limited. We characterized 219 GBS isolates recovered from vaginal screening cultures at a general hospital in Osaka Prefecture, Japan between 2021 and 2023. Capsular type, clonal complex/sequence type (CC/ST), virulence factors (pilus islands, Alp family, Srr1/Srr2, and HvgA), and antimicrobial resistance determinants were analyzed using whole-genome sequencing. The predominant lineages were CC19 (27.9%), CC23 (21.9%), and CC1 (21.0%), whereas the hypervirulent CC17 lineage accounted for only 5.5% of isolates. Capsular type Ia, III, and V comprised >60% of the isolates. PI-1/PI-2a (58.0%) was the predominant pilus profile, and rib (35.2%) was the most frequent Alp family gene. The hypervirulence-associated markers hvgA and srr2 were confined to capsular types III/CC17 and IV/CC452. All isolates were susceptible to β-lactams and vancomycin, whereas resistance to macrolides, clindamycin, and levofloxacin was observed at varying frequencies. These findings provide a pre-vaccine molecular baseline for maternal GBS carriage in Japan and highlight srr2 -positive CC452 as a potential emerging lineage of concern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Mimihara General Hospital, Sakai, Osaka, Japan.
- Department of Clinical Laboratory Science, Kansai University of Health Sciences, Sennan-gun, Osaka, Japan.
- Department of Obstetrics and Gynecology, Mimihara General Hospital, Sakai, Osaka, Japan.
- Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Higashimurayama-shi, Tokyo, Japan.
ORCID-Profile: Hirofumi Ohtaki, Masaki Karino, Satoshi Nakano
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Nishi, C., Ohtaki, H., Karino, M., Uekita, H., Sano, A., Kobayashi, T., Kaino, S., Sakamoto, Y., & Nakano, S. (2026). Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023. PLOS One, 21(7), e0354799. https://doi.org/10.1371/journal.pone.0354799
Vancouver
Nishi C, Ohtaki H, Karino M, Uekita H, Sano A, Kobayashi T, et al. Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023. PLOS One. 2026;21(7):e0354799. doi:10.1371/journal.pone.0354799
BibTeX
@article{Nishi2026,
author = {Nishi, Chizu and Ohtaki, Hirofumi and Karino, Masaki and Uekita, Hiromi and Sano, Ayumi and Kobayashi, Tetsuya and Kaino, Susumu and Sakamoto, Yoshiki and Nakano, Satoshi},
title = {Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0354799},
doi = {10.1371/journal.pone.0354799}
}
EUVIMED